Literature DB >> 8904405

Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture.

H Karch1, C Janetzki-Mittmann, S Aleksic, M Datz.   

Abstract

We examined 30 children with classical hemolytic-uremic syndrome (HUS) for the presence of enterohemorrhagic Escherichia coli (EHEC) strains in stool samples and determined the specific immune response to O157 lipopolysaccharide in acute-phase serum samples from these patients. EHEC O157 strains were isolated from stool samples of 18 (60%) of the patients, and non-O157 EHEC strains were isolated from 5 (17%) of the patients. For O157 strain isolation from stools, we introduced a selective enrichment step using O157-specific antibodies attached to paramagnetic particles (immunomagnetic separation [IMS] method). This procedure allowed the detection of O157 strains at 10(2) CFU/g of stool in the presence of 10(7) coliform background flora organisms. By using IMS followed by plating on sorbitol MacConkey (SMAC) agar and cefixime-tellurite SMAC (CT-SMAC) agar, O157 strains were detected in 18 samples, whereas colony hybridization detected a subset of 12 positive samples and direct culture on CT-SMAC or SMAC agar detected only 7. Three of the 18 O157-positive stools were negative by cytotoxicity assay performed with stool filtrates and by direct PCR with DNA extracted from stools. The IMS technique allowed the isolation of O157 strains from 18 of 20 patients with serological evidence for O157 infection. Apart from the increase in sensitivity in O157 detection compared with that of direct culture, the IMS technique also has the advantage of being less labor-intensive and less time-consuming than the molecular methods. IMS can therefore be considered an efficient method for wide-spread use in the detection of O157 strains in clinical microbiology laboratories. However, because a significant number of HUS cases were attributable to non-O157 EHEC serogroups, the use of additional methods besides IMS in the bacteriological diagnosis of HUS is necessary.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904405      PMCID: PMC228837          DOI: 10.1128/jcm.34.3.516-519.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  The use of sorbitol-MacConkey agar in conjunction with a specific antiserum for the detection of Vero cytotoxin-producing strains of Escherichia coli O 157.

Authors:  H Kleanthous; N K Fry; H R Smith; R J Gross; B Rowe
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

2.  Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology.

Authors:  P I Tarr; M A Neill; C R Clausen; S L Watkins; D L Christie; R O Hickman
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

3.  Immunomagnetic separation as a sensitive method for isolating Escherichia coli O157 from food samples.

Authors:  D J Wright; P A Chapman; C A Siddons
Journal:  Epidemiol Infect       Date:  1994-08       Impact factor: 2.451

4.  A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home.

Authors:  A O Carter; A A Borczyk; J A Carlson; B Harvey; J C Hockin; M A Karmali; C Krishnan; D A Korn; H Lior
Journal:  N Engl J Med       Date:  1987-12-10       Impact factor: 91.245

5.  Direct detection of verotoxin-producing Escherichia coli in stool samples by PCR.

Authors:  K Ramotar; B Waldhart; D Church; R Szumski; T J Louie
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

6.  Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli.

Authors:  A Caprioli; I Luzzi; F Rosmini; C Resti; A Edefonti; F Perfumo; C Farina; A Goglio; A Gianviti; G Rizzoni
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

7.  Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes.

Authors:  S M Scotland; B Rowe; H R Smith; G A Willshaw; R J Gross
Journal:  J Med Microbiol       Date:  1988-04       Impact factor: 2.472

8.  Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases.

Authors:  H Karch; H Rüssmann; H Schmidt; A Schwarzkopf; J Heesemann
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome.

Authors:  H Rüssmann; H Schmidt; J Heesemann; A Caprioli; H Karch
Journal:  J Med Microbiol       Date:  1994-05       Impact factor: 2.472

View more
  27 in total

Review 1.  Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(-) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis.

Authors:  H Karch; M Bielaszewska
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

2.  Outbreak of Escherichia coli O157:H7 infection in a large family.

Authors:  K Ludwig; H Ruder; M Bitzan; S Zimmermann; H Karch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

Review 3.  Current and developing technologies for monitoring agents of bioterrorism and biowarfare.

Authors:  Daniel V Lim; Joyce M Simpson; Elizabeth A Kearns; Marianne F Kramer
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

4.  Improvement of the immunomagnetic separation method selective for Escherichia coli O157 strains.

Authors:  T Tomoyasu
Journal:  Appl Environ Microbiol       Date:  1998-01       Impact factor: 4.792

5.  Genetic analysis of H1N1 influenza virus from throat swab samples in a microfluidic system for point-of-care diagnostics.

Authors:  B Scott Ferguson; Steven F Buchsbaum; Ting-Ting Wu; Kuangwen Hsieh; Yi Xiao; Ren Sun; H Tom Soh
Journal:  J Am Chem Soc       Date:  2011-05-24       Impact factor: 15.419

6.  Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.

Authors:  Kerstin Ludwig; Volkan Sarkim; Martin Bitzan; Mohamed A Karmali; Christoph Bobrowski; Hans Ruder; Rainer Laufs; Ingo Sobottka; Martin Petric; Helge Karch; Dirk E Müller-Wiefel
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

7.  Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome.

Authors:  K Ludwig; M A Karmali; V Sarkim; C Bobrowski; M Petric; H Karch; D E Müller-Wiefel
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

8.  Solid-phase capture of proteins, spores, and bacteria.

Authors:  B C Weimer; M K Walsh; C Beer; R Koka; X Wang
Journal:  Appl Environ Microbiol       Date:  2001-03       Impact factor: 4.792

9.  PCR-based DNA amplification and presumptive detection of Escherichia coli O157:H7 with an internal fluorogenic probe and the 5' nuclease (TaqMan) assay.

Authors:  R D Oberst; M P Hays; L K Bohra; R K Phebus; C T Yamashiro; C Paszko-Kolva; S J Flood; J M Sargeant; J R Gillespie
Journal:  Appl Environ Microbiol       Date:  1998-09       Impact factor: 4.792

10.  Phylogeny, clinical associations, and diagnostic utility of the pilin subunit gene (sfpA) of sorbitol-fermenting, enterohemorrhagic Escherichia coli O157:H-.

Authors:  Alexander W Friedrich; Katja V Nierhoff; Martina Bielaszewska; Alexander Mellmann; Helge Karch
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.